SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today unveiled a new product for Molecular Cytogeneticists: the Infinium® High-Density (HD) HumanCytoSNP-12 DNA Analysis BeadChip. The HumanCytoSNP-12 BeadChip contains nearly 300,000 genetic markers per sample that target all known cytogenetic abnormalities found in genes and disease pathways linked to mental retardation, autism, and other common chromosome anomalies. Priced as low as $125 per sample, the HumanCytoSNP-12 BeadChip is part of a complete cytogenetic solution available from Illumina. To complement the HumanCytoSNP-12 BeadChip, Illumina is also releasing a dedicated cytogenetic software package called KaryoStudio.
